Tokyo Tape
Sign in
← Medical Ikkou Group

Quarterly report · Q2

3353.TEDINET S100PCTW
Period2022-03-01 → 2022-08-31
Filed2022-10-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥17.0bn2022-03-01 → 2022-08-31Cons.Net sales
Revenue¥33.6bn2021-03-01 → 2022-02-28Cons.Net sales (5-year summary)
Revenue¥16.8bn2021-03-01 → 2021-08-31Cons.Net sales
Operating income¥466m2022-03-01 → 2022-08-31Cons.Operating income
Operating income¥645m2021-03-01 → 2021-08-31Cons.Operating income
Ordinary income¥598m2022-03-01 → 2022-08-31Cons.Ordinary income
Ordinary income¥1.4bn2021-03-01 → 2022-02-28Cons.Ordinary income loss (5-year summary)
Ordinary income¥682m2021-03-01 → 2021-08-31Cons.Ordinary income
Profit before tax¥624m2022-03-01 → 2022-08-31Cons.Income before income taxes
Profit before tax¥781m2021-03-01 → 2021-08-31Cons.Income before income taxes
Net income (owners)¥374m2022-03-01 → 2022-08-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥852m2021-03-01 → 2022-02-28Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥444m2021-03-01 → 2021-08-31Cons.Profit loss attributable to owners of parent
Net income¥386m2022-03-01 → 2022-08-31Cons.Profit loss
Net income¥452m2021-03-01 → 2021-08-31Cons.Profit loss
Total assets¥28.3bnat 2022-08-31Cons.Assets
Total assets¥29.1bnat 2022-02-28Cons.Assets
Total assets¥30.2bnat 2021-08-31Cons.Total assets (5-year summary)
Total liabilities¥16.1bnat 2022-08-31Cons.Liabilities
Total liabilities¥17.2bnat 2022-02-28Cons.Liabilities
Net assets / equity¥12.2bnat 2022-08-31Cons.Net assets
Net assets / equity¥11.9bnat 2022-02-28Cons.Net assets
Net assets / equity¥11.6bnat 2021-08-31Cons.Net assets (5-year summary)
Cash and deposits¥7.0bnat 2022-08-31Cons.Cash and deposits
Cash and deposits¥8.0bnat 2022-02-28Cons.Cash and deposits
Cash & equivalents¥6.8bnat 2022-08-31Cons.Cash and cash equivalents
Cash & equivalents¥7.8bnat 2022-02-28Cons.Cash and cash equivalents
Cash & equivalents¥8.4bnat 2021-08-31Cons.Cash and cash equivalents
Cash & equivalents¥6.8bnat 2021-02-28dCons.Cash and cash equivalents
Operating cash flow¥496m2022-03-01 → 2022-08-31Cons.Net cash provided by used in operating activities
Operating cash flow¥1.1bn2021-03-01 → 2022-02-28Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥334m2021-03-01 → 2021-08-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥291m2022-03-01 → 2022-08-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥216m2021-03-01 → 2022-02-28Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥47m2021-03-01 → 2021-08-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥1.2bn2022-03-01 → 2022-08-31Cons.Net cash provided by used in financing activities
Financing cash flow¥65m2021-03-01 → 2022-02-28Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.3bn2021-03-01 → 2021-08-31Cons.Net cash provided by used in financing activities
EPS (basic)¥99.652022-03-01 → 2022-08-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥44.262022-06-01 → 2022-08-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥226.922021-03-01 → 2022-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥118.222021-03-01 → 2021-08-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥58.132021-06-01 → 2021-08-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio41.2%at 2022-08-31Cons.Equity to asset ratio (5-year summary)
Equity ratio39.1%at 2022-02-28Cons.Equity to asset ratio (5-year summary)
Equity ratio36.6%at 2021-08-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-03-01 → 2022-08-31−¥497m
Reconciling Itemsreconcilingrevenue intersegment2022-03-01 → 2022-08-31−¥497m
Reconciling Itemsreconcilingsegment profit2022-03-01 → 2022-08-31−¥385m
jpcrp040300-q2r_E03443-000Dispensing Pharmacyreportable segmentrevenue2022-03-01 → 2022-08-31¥11.6bn
jpcrp040300-q2r_E03443-000Dispensing Pharmacyreportable segmentrevenue external2022-03-01 → 2022-08-31¥11.6bn
jpcrp040300-q2r_E03443-000Dispensing Pharmacyreportable segmentsegment profit2022-03-01 → 2022-08-31¥736m
jpcrp040300-q2r_E03443-000Health Carereportable segmentrevenue2022-03-01 → 2022-08-31¥3.9bn
jpcrp040300-q2r_E03443-000Health Carereportable segmentrevenue external2022-03-01 → 2022-08-31¥3.9bn
jpcrp040300-q2r_E03443-000Health Carereportable segmentrevenue intersegment2022-03-01 → 2022-08-31¥300,000
jpcrp040300-q2r_E03443-000Health Carereportable segmentsegment profit2022-03-01 → 2022-08-31¥35m
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentrevenue2022-03-01 → 2022-08-31¥1.9bn
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentrevenue external2022-03-01 → 2022-08-31¥1.4bn
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentrevenue intersegment2022-03-01 → 2022-08-31¥495m
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentsegment profit2022-03-01 → 2022-08-31¥20m
jpcrp040300-q2r_E03443-000Real Estatereportable segmentrevenue2022-03-01 → 2022-08-31¥95m
jpcrp040300-q2r_E03443-000Real Estatereportable segmentrevenue external2022-03-01 → 2022-08-31¥94m
jpcrp040300-q2r_E03443-000Real Estatereportable segmentrevenue intersegment2022-03-01 → 2022-08-31¥876,000
jpcrp040300-q2r_E03443-000Real Estatereportable segmentsegment profit2022-03-01 → 2022-08-31¥61m
Total Of Reportable Segments And Otherssegment totalrevenue2022-03-01 → 2022-08-31¥17.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-03-01 → 2022-08-31¥17.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-03-01 → 2022-08-31¥497m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-03-01 → 2022-08-31¥851m
Reconciling Itemsreconcilingrevenue2021-03-01 → 2021-08-31−¥545m
Reconciling Itemsreconcilingrevenue intersegment2021-03-01 → 2021-08-31−¥545m
Reconciling Itemsreconcilingsegment profit2021-03-01 → 2021-08-31−¥347m
jpcrp040300-q2r_E03443-000Dispensing Pharmacyreportable segmentrevenue2021-03-01 → 2021-08-31¥11.3bn
jpcrp040300-q2r_E03443-000Dispensing Pharmacyreportable segmentrevenue external2021-03-01 → 2021-08-31¥11.3bn
jpcrp040300-q2r_E03443-000Dispensing Pharmacyreportable segmentsegment profit2021-03-01 → 2021-08-31¥731m
jpcrp040300-q2r_E03443-000Health Carereportable segmentrevenue2021-03-01 → 2021-08-31¥3.9bn
jpcrp040300-q2r_E03443-000Health Carereportable segmentrevenue external2021-03-01 → 2021-08-31¥3.9bn
jpcrp040300-q2r_E03443-000Health Carereportable segmentrevenue intersegment2021-03-01 → 2021-08-31¥300,000
jpcrp040300-q2r_E03443-000Health Carereportable segmentsegment profit2021-03-01 → 2021-08-31¥146m
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentrevenue2021-03-01 → 2021-08-31¥2.0bn
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentrevenue external2021-03-01 → 2021-08-31¥1.4bn
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentrevenue intersegment2021-03-01 → 2021-08-31¥543m
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentsegment profit2021-03-01 → 2021-08-31¥50m
jpcrp040300-q2r_E03443-000Real Estatereportable segmentrevenue2021-03-01 → 2021-08-31¥117m
jpcrp040300-q2r_E03443-000Real Estatereportable segmentrevenue external2021-03-01 → 2021-08-31¥116m
jpcrp040300-q2r_E03443-000Real Estatereportable segmentrevenue intersegment2021-03-01 → 2021-08-31¥960,000
jpcrp040300-q2r_E03443-000Real Estatereportable segmentsegment profit2021-03-01 → 2021-08-31¥65m
Total Of Reportable Segments And Otherssegment totalrevenue2021-03-01 → 2021-08-31¥17.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-03-01 → 2021-08-31¥16.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-03-01 → 2021-08-31¥545m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-03-01 → 2021-08-31¥992m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 501
ItemContextValueUnit
Payments for lease and guarantee deposits inv cfPrior1YTDDuration-1005000JPY
Payments for lease and guarantee deposits inv cfCurrentYTDDuration-113150000JPY
Proceeds from collection of lease and guarantee deposits inv cfPrior1YTDDuration2222000JPY
Proceeds from collection of lease and guarantee deposits inv cfCurrentYTDDuration44552000JPY
Other net inv cfPrior1YTDDuration9613000JPY
Other net inv cfCurrentYTDDuration-19361000JPY
Net cash provided by used in investment activitiesPrior1YTDDuration-46527000JPY
Net cash provided by used in investment activitiesCurrentYTDDuration-291276000JPY
Net increase decrease in short term loans payable fin cfPrior1YTDDuration-80000000JPY
Net increase decrease in short term loans payable fin cfCurrentYTDDuration-10000000JPY
Proceeds from long term loans payable fin cfPrior1YTDDuration2550000000JPY
Proceeds from long term loans payable fin cfCurrentYTDDuration650000000JPY
Repayment of long term loans payable fin cfPrior1YTDDuration-1809023000JPY
Repayment of long term loans payable fin cfCurrentYTDDuration-1716268000JPY
Repayments of lease obligations fin cfPrior1YTDDuration-21712000JPY
Repayments of lease obligations fin cfCurrentYTDDuration-12484000JPY
Proceeds from share issuance to non controlling shareholders fin cfPrior1YTDDuration750000000JPY
Proceeds from share issuance to non controlling shareholders fin cfCurrentYTDDuration－JPY
Cash dividends paid fin cfPrior1YTDDuration-75123000JPY
Cash dividends paid fin cfCurrentYTDDuration-75120000JPY
Net cash provided by used in financing activitiesPrior1YTDDuration1314140000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration-1163874000JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration1602045000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration-958851000JPY
Cash and cash equivalentsPrior2YearInstant6805529000JPY
Cash and cash equivalentsPrior1YearInstant7789797000JPY
Cash and cash equivalentsPrior1QuarterInstant8407574000JPY
Cash and cash equivalentsCurrentQuarterInstant6830946000JPY
Directors compensations sgaPrior1YTDDuration135454000JPY
Directors compensations sgaCurrentYTDDuration125319000JPY
Payroll and allowances sgaPrior1YTDDuration285881000JPY
Payroll and allowances sgaCurrentYTDDuration291077000JPY
Provision for bonuses sgaPrior1YTDDuration19791000JPY
Provision for bonuses sgaCurrentYTDDuration16239000JPY
Retirement benefit expenses sgaPrior1YTDDuration6202000JPY
Retirement benefit expenses sgaCurrentYTDDuration6876000JPY
Provision of allowance for doubtful accounts sgaPrior1YTDDuration1000JPY
Provision of allowance for doubtful accounts sgaCurrentYTDDuration318000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E03443-000DispensingPharmacyReportableSegmentsMember11336945000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E03443-000HealthCareReportableSegmentsMember3935598000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E03443-000MedicalProductsWholesaleReportableSegmentsMember1424274000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E03443-000RealEstateReportableSegmentsMember116175000JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember16812994000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration16812994000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E03443-000DispensingPharmacyReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E03443-000HealthCareReportableSegmentsMember300000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E03443-000MedicalProductsWholesaleReportableSegmentsMember543466000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E03443-000RealEstateReportableSegmentsMember960000JPY
Transactions with other segmentsPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember544726000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-02-28pass
balance sheet identityconsolidated 2022-08-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-02-28pass
statement vs summary · net assetsconsolidated 2022-08-31pass
statement vs summary · net income attributable to parentconsolidated 2021-03-01/2021-08-31pass
statement vs summary · net income attributable to parentconsolidated 2022-03-01/2022-08-31pass
statement vs summary · operating cash flowconsolidated 2021-03-01/2021-08-31pass
statement vs summary · operating cash flowconsolidated 2022-03-01/2022-08-31pass
statement vs summary · revenueconsolidated 2021-03-01/2021-08-31pass
statement vs summary · revenueconsolidated 2022-03-01/2022-08-31pass
statement vs summary · total assetsconsolidated 2022-02-28pass
statement vs summary · total assetsconsolidated 2022-08-31pass